UnknownNot Applicable

A Prospective Study of Surgical Treatment Strategies for Chordoma

China100 participantsStarted 2023-02-01

Plain-language summary

Chordoma is a rare but locally invasive cancer that arises from the embryonic notochord. Total resection is challenging in mobile spine because of the complex anatomy and bone invasion.

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Between the ages of 18 and 70 ys, * With a diagnosis of chordoma confirmed by pathology, * Undergone surgical treatment in our hospital, * Available for clinical follow-up and agree to long-term clinical follow-up and sign informed consent. Exclusion Criteria: * Suffer from other tumors, * Suffer from cardiovascular disease, cerebrovascular disease, or immune system disease.

What they're measuring

Excision Extension

Timeframe: 1 week after surgery.

Trial details

NCT IDNCT05707767

SponsorXuanwu Hospital, Beijing

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-09-30

View on ClinicalTrials.gov More Chordoma of Spine trials